Facebook
Twitter
Telegram
Report an ErrorAvadel Pharmaceuticals plc Balance Sheet 2011-2024 | AVDL
Annual Balance Sheet Avadel Pharmaceuticals plc
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-28.5 M | -72.2 M | 92.6 M | 56.6 M | 166 M | 107 M | -16.3 M | -38.4 M | -63.9 M | 78.7 M | 78.9 M | 33.9 M | 259 K |
Long Term Debt |
1.69 M | 780 K | 142 M | 128 M | 122 M | 116 M | 156 K | 547 K | 684 K | 76.1 M | 66.3 M | 33.3 M | 1.69 M |
Long Term Debt Current |
934 K | 960 K | 900 K | 474 K | 645 K | 106 K | 111 K | 268 K | 434 K | 42.3 M | 19.2 M | 3.35 M | 2.03 M |
Total Non Current Liabilities |
- | - | - | 134 M | 145 M | 149 M | 81.2 M | 141 M | 98.3 M | 78.5 M | 85.2 M | 72.4 M | 21.3 M |
Total Current Liabilities |
36.9 M | 55.8 M | 21 M | 15.1 M | 36 M | 38.4 M | 86.5 M | 62.4 M | 48.8 M | 70.7 M | 39.7 M | 14.4 M | 18.3 M |
Total Liabilities |
77 M | 154 M | 169 M | 149 M | 181 M | 188 M | 168 M | 203 M | 147 M | 149 M | 126 M | 86.8 M | 39.6 M |
Deferred Revenue |
- | - | - | - | - | 114 K | 2.01 M | 2.22 M | 5.12 M | 1.34 M | 1.38 M | 1.19 M | 4.8 M |
Retained Earnings |
-745 M | -585 M | -448 M | -384 M | -391 M | -358 M | -263 M | -320 M | -280 M | -320 M | -236 M | -193 M | -189 M |
Total Assets |
165 M | 133 M | 247 M | 312 M | 151 M | 190 M | 253 M | 245 M | 215 M | 174 M | 116 M | 117 M | 69.4 M |
Cash and Cash Equivalents |
31.2 M | 74 M | 50.7 M | 71.7 M | 9.77 M | 9.32 M | 16.6 M | 39.2 M | 65.1 M | 39.8 M | 6.64 M | 2.74 M | 3.46 M |
Book Value |
87.7 M | -21.1 M | 78.2 M | 162 M | -29.2 M | 2.78 M | 85.6 M | 42.1 M | 67.9 M | 24.9 M | -9.51 M | 30.5 M | 29.8 M |
Total Shareholders Equity |
87.7 M | -21.1 M | 78.2 M | 162 M | -29.2 M | 2.78 M | 85.6 M | 42.1 M | 69.1 M | 25 M | -9.51 M | 30.5 M | 29.8 M |
All numbers in USD currency
Quarterly Balance Sheet Avadel Pharmaceuticals plc
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
1.45 M | 1.69 M | 1.93 M | - | 93.1 M | 780 K | 110 M | 108 M | 117 M | 142 M | 142 M | 142 M | 141 M | 128 M | 128 M | 128 M | 128 M | 122 M | 122 M | 122 M | 122 M | 116 M | 116 M | 116 M | 116 M | 156 K | 156 K | 156 K | 156 K | 547 K | 547 K | 547 K | 547 K | 684 K | 684 K | 684 K | 684 K | 1.28 M | 68 M | 69.4 M | 56.6 M | 66.3 M | 65.4 M | 78 M | - | 33.3 M | - | 47.8 M | 47.8 M | 1.69 M | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 120 M | 86.5 M | 78.5 M | 76.6 M | 78.9 M | 66.3 M | 77.5 M | 98.3 M | 111 M | - | 72.4 M | - | 92.1 M | 88.2 M | 21.3 M | - | - | - |
Total Liabilities |
89.5 M | 77 M | 93 M | 57.8 M | 179 M | 154 M | 158 M | 161 M | 166 M | 169 M | 165 M | 164 M | 156 M | 149 M | 149 M | 149 M | 149 M | 181 M | 181 M | 181 M | 181 M | 188 M | 188 M | 188 M | 188 M | 168 M | 168 M | 168 M | 168 M | 203 M | 203 M | 203 M | 203 M | 146 M | 146 M | 146 M | 147 M | 149 M | - | - | - | 698 K | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 114 K | - | - | - | 2.01 M | 1.93 M | 2.46 M | 1.62 M | 2.22 M | 2.22 M | 2.22 M | 2.22 M | 5.12 M | 5.12 M | 5.12 M | 5.12 M | 1.34 M | 612 K | 954 K | 157 K | 1.26 M | 1 M | 190 K | - | 614 K | - | 2.49 M | 2.98 M | 2.84 M | - | - | - |
Retained Earnings |
-773 M | -745 M | -717 M | -680 M | -616 M | -585 M | -558 M | -538 M | -474 M | -448 M | -425 M | -403 M | -384 M | -384 M | -384 M | -384 M | -384 M | -391 M | -391 M | -391 M | -391 M | -358 M | -358 M | -358 M | -358 M | -263 M | -263 M | -263 M | -263 M | -320 M | -320 M | -320 M | -320 M | -279 M | -279 M | -279 M | -280 M | -320 M | -293 M | -283 M | -262 M | -236 M | -241 M | -234 M | - | -193 M | - | -195 M | -189 M | -189 M | - | - | - |
Total Assets |
168 M | 165 M | 203 M | 201 M | 141 M | 133 M | 146 M | 158 M | 221 M | 247 M | 264 M | 283 M | 293 M | 312 M | 312 M | 312 M | 312 M | 151 M | 151 M | 151 M | 151 M | 190 M | 190 M | 190 M | 190 M | 253 M | 253 M | 253 M | 253 M | 245 M | 245 M | 245 M | 245 M | 215 M | 215 M | 215 M | 215 M | 174 M | 164 M | 175 M | 182 M | 116 M | 117 M | 118 M | - | 117 M | - | 134 M | 137 M | 69.4 M | - | - | - |
Cash and Cash Equivalents |
35.8 M | 31.2 M | 51.8 M | 50 M | 83.4 M | 74 M | 60.7 M | 54.1 M | 60.9 M | 50.7 M | 58.2 M | 67.1 M | 59.2 M | 71.7 M | 71.7 M | 71.7 M | 71.7 M | 9.77 M | 9.77 M | 9.77 M | 9.77 M | 9.32 M | 9.32 M | 9.32 M | 9.32 M | 16.6 M | 16.6 M | 16.6 M | 16.6 M | 39.2 M | 39.2 M | 39.2 M | 39.2 M | 65.1 M | 65.1 M | 65.1 M | 65.1 M | 39.8 M | 24 M | 54.1 M | 55.5 M | 6.64 M | 7.8 M | 8.34 M | 14 M | 2.74 M | 3.12 M | 4.76 M | 4.35 M | 3.46 M | - | 11.6 M | 5.83 M |
Book Value |
78.4 M | 87.7 M | 110 M | 143 M | -38.2 M | -21.1 M | -12.4 M | -3.33 M | 55.2 M | 78.2 M | 99 M | 119 M | 137 M | 162 M | 162 M | 162 M | 162 M | -29.2 M | -29.2 M | -29.2 M | -29.2 M | 2.78 M | 2.78 M | 2.78 M | 2.78 M | 85.6 M | 85.6 M | 85.6 M | 85.6 M | 42.1 M | 42.1 M | 42.1 M | 42.1 M | 69.1 M | 69.1 M | 69.1 M | 67.9 M | 24.9 M | 164 M | 175 M | 182 M | 116 M | 117 M | 118 M | - | 117 M | - | 134 M | 137 M | 69.4 M | - | - | - |
Total Shareholders Equity |
78.4 M | 87.7 M | 110 M | 143 M | -38.2 M | -21.1 M | -12.4 M | -3.33 M | 55.2 M | 78.2 M | 99 M | 119 M | 137 M | 162 M | 162 M | 162 M | 162 M | -29.2 M | -29.2 M | -29.2 M | -29.2 M | 2.78 M | 2.78 M | 2.78 M | 2.78 M | 85.6 M | 85.6 M | 85.6 M | 85.6 M | 42.1 M | 42.1 M | 42.1 M | 42.1 M | 69.1 M | 69.1 M | 69.1 M | 67.9 M | 25 M | 40 M | 57.9 M | 78.1 M | -8.82 M | -15.4 M | -10.1 M | - | 30.5 M | - | 25.4 M | 32 M | 29.8 M | - | - | - |
All numbers in USD currency